Accessibility Menu
 
Green Thumb Industries logo

Green Thumb Industries

(OTC) GTBIF

Current Price$5.77
Market Cap$1.42B
Since IPO (2018)-23%
5 Year-80%
1 Year+11%
1 Month-8%

Green Thumb Industries Financials at a Glance

Market Cap

$1.42B

Revenue (TTM)

$1.18B

Net Income (TTM)

$115.17M

EPS (TTM)

$0.49

P/E Ratio

12.59

Dividend

$0.00

Beta (Volatility)

0.76 (Low)

Price

$5.77

Volume

441,884

Open

$6.10

Previous Close

$5.77

Daily Range

$5.74 - $6.23

52-Week Range

$4.63 - $10.43

GTBIF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Green Thumb Industries

Industry

Pharmaceuticals

Employees

5,000

CEO

Benjamin Kovler, MBA

Headquarters

Chicago, IL 60654, US

GTBIF Financials

Key Financial Metrics (TTM)

Gross Margin

47%

Operating Margin

12%

Net Income Margin

10%

Return on Equity

6%

Return on Capital

5%

Return on Assets

4%

Earnings Yield

7.94%

Dividend Yield

0.00%

Payout Ratio

2.70%

Stock Overview

Market Cap

$1.42B

Shares Outstanding

231.54M

Volume

441.88K

Short Interest

0.00%

Avg. Volume

607.31K

Financials (TTM)

Gross Profit

$574.89M

Operating Income

$140.11M

EBITDA

$485.00M

Operating Cash Flow

$294.93M

Capital Expenditure

$81.07M

Free Cash Flow

$213.86M

Cash & ST Invst.

$274.30M

Total Debt

$517.41M

Green Thumb Industries Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$311.13M

+5.7%

Gross Profit

$141.34M

-10.6%

Gross Margin

45.43%

N/A

Market Cap

$1.42B

N/A

Market Cap/Employee

$289.66K

N/A

Employees

4,900

N/A

Net Income

$84.48M

+566.3%

EBITDA

$207.23M

+373.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$243.11M

+32.3%

Accounts Receivable

$103.85M

+94.0%

Inventory

$0.00

-100.0%

Long Term Debt

$480.63M

-4.7%

Short Term Debt

$36.78M

+39.5%

Return on Assets

4.14%

N/A

Return on Invested Capital

5.29%

N/A

Free Cash Flow

$75.46M

+367.5%

Operating Cash Flow

$90.14M

+108.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHIZFChina Traditional Chinese Medicine Holdings Co. Limited
$0.27+0.00%
SWGHFSawai Group Holdings Co., Ltd.
$11.52+0.00%
PHMMFPharma Mar, S.A.
$92.19+3.91%
KSPHFKissei Pharmaceutical Co., Ltd.
$25.77+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About GTBIF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.